CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Editor's Corner
Update on Carotid Stenting: What Went Wrong?
Frank J. Criado, Editor-in-Chief
Vascular Surgery and Endovascular Intervention; Union Memorial Hospital/MedStar Health, Baltimore, Maryland
frank.criado@medstar.net
____________________________
“… the procedure is expected to greatly reduce the demand for a common operation in which surgeons slice open the neck and scrape the carotids clean from earlobe to collarbone”.
“The shift to angioplasty has drawn fervent opposition from surgeons who question angioplasty’s long-term effectiveness and safety…They also stand to lose a major source of income…”1
Going below the knee: Not without challenges
By all accounts, leg ischemia caused by below-the-knee (BTK) arterial occlusive arterial lesions is an important and frequent form of atherosclerotic vascular disease. Until the recent past, BTK revascularization was long considered a “sacred domain” of surgical (bypass) treatment — with little if any room left for catheter-based therapy. We know better today.1 The BTK territory, in fact, can be appropriately thought of today as one of the most promising frontiers in the entire endovascular field when the potential for growth and patient benefit are taken into account.
Balloon angiop
This is a Test article
Blah blah blah
On the Nature of Turf Wars: Disruptive Technologies Did It!
When offered the position of Editor-in-Chief at VDM, I was told that I would have a great deal of freedom to generate my imprint on this publication, and a few privileges; perhaps a little glamour as well. I was also given the “power” to over-rule (if necessary) manuscript reviewers and make some decisions of my own — provided they were rational and based on compelling reasons. Well, I finally found something worthy of such a stance!
The article by Baerlocher, et al. on uterine artery embolization was submitted to VDM and put through the usual peer-review process. The assigned revie
Retrievable IVC Filters: Advance or Gimmick?
The article by Arko et al1 served as the foundation for this editorial. The paper describes a first-in-man clinical experience (10 patients) with a new retrievable vena cava filter (VCF). The design of the Crux IVCF appears unique and quite interesting. Instead of the more standard conical, strut-and-hook designs we have all seen many times in the past, this new device features a symmetrical double-loop helical construct. It is meant to be self-centering within the lumen of the vena cava and provide “consistent clot trapping over the entire inferior vena cava (IVC) circumference
Stent-Graft Repair of Thoracic Aortic Diseases: A New Frontier in Endovascular Therapy
The FDA announced approval of the first thoracic endograft device (Gore TAG) on March 23, 2005. It signaled the true beginning of a new era in endovascular therapy, and the unmistakable 'message' that thoracic aortic surgery is about to be transformed in a dramatic and irreversible fashion.
Thoracic aortic diseases, such as aneurysms, dissection, and others, share in common several important features - a relatively high incidence and high lethal potential, among others! Open surgical repair has been the acknowledged standard of care for decades, but it is far from ideal because of continuin
Cartoid Stentng: The Perfect Vascular Storm! (coming to a hospital near you...)
It may sound pretentious, even a little arrogant, but as a vascular surgeon who has gained a great deal of experience and confidence with both endarterectomy (CEA) and stenting (CAS) over the years, I feel uniquely qualified to express strong views on this, the most important vascular topic of the day. I count myself among a group of ‘senior’ endovascular specialists whose interventional journey began in the 1980s. As such, we had the opportunity to witness and actively participate in a number of significant developments with new technologies and techniques. Some of these, in fact
Welcome to Vascular Disease Management
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM). This is a truly unique publication that was designed with the multi-disciplinary nature of today’s vascular team in mind. It intends to become a readily available source of practically important information and a forum for the dissemination of current opinions and changing standards in this rapidly evolving field.
Unlike many of the established peer-review journals, VDM incorporates a unique format which places great em
On the Nature of Turf Wars II: Discussing the Anatomy of Vascular Disruptions
I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that! Instead, I’m sure they were largely reflective of the relevance and timeliness of the topic itself. Turf Wars have been and are in all of our minds. They exist, powerfully and unequivocally, and — to put it simply — cannot be ignored. Furthermore, they carry significant destructive (and distracting) potential. I have therefore decided to dedicate th
Stent-Graft Technologies 2008: AAA Conquered
More than half of all abdominal aortic aneurysm (AAA) repairs performed in the U.S. today are being done endovascularly. In other words, stent-graft intervention has already replaced the old open-surgery standard. Undeniably, this represents a very important and amazing development involving a therapy that is less than 20 years old from primordial inception (1990)… and less than 10 years after the initial FDA approvals (late September 1999).
AAA is an important disease process, affecting an estimated 2 million people in the United States alone. Ruptured AAA rank
Digital Supplements Using Advanced Technology to |
 Superior Mesenteric Artery Revascularization and |
Vascular Disease News Wire
- Thursday, December 11, 2008 - 16:23
- Monday, November 24, 2008 - 11:56
- Monday, October 6, 2008 - 10:02
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
 LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 Phone: (305) 604-1601 Toll Free: 1-877-563-9762 This activity is sponsored by the North American Center for Continuing Medical Education. |
 CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 This activity is supported by an educational grant from Bracco Diagnostics Inc. |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
